Table 1.
Baseline Demographic and Clinical Characteristics
| Placebo | Fish Oil | ||
|---|---|---|---|
| Variable1 | (n=18) | (n=21) | P-value2 |
| Age, years | 14.1 ± 2.8 | 14.7 ± 2.9 | 0.6 |
| Gender, n (%) female | 13 (72) | 17 (81) | 0.1 |
| Race, n (%) White | 11 (61) | 14 (67) | 0.4 |
| Prepubescent, n (%) | 2 (11) | 2 (10) | 1.0 |
| BMI, kg/m2 | 26.1 ± 8.5 | 26.4 ± 8.5 | 0.9 |
| WASI | 103.0 ± 13.0 | 100.3 ± 10.9 | 0.5 |
| Diagnosis, n (%) | |||
| MDD | 13 (72) | 16 (76) | 0.5 |
| Depressive Disorder NOS | 5 (28) | 5 (24) | 0.5 |
| CDRS-R Total Score | 49.1 ± 7.9 | 46.4 ± 7.1 | 0.3 |
| CGI-S | 4.6 ± 0.5 | 4.5 ± 0.6 | 0.5 |
| Erythrocyte Fatty acids (wt % TTL) | |||
| EPA+DHA | 3.3 ± 0.7 | 3.3 ± 0.6 | 0.8 |
| AA | 17.9 ± 1.2 | 17.3 ± 1.7 | 0.2 |
| AA/EPA+DHA | 5.5 ± 1.0 | 5.4 ± 1.0 | 0.7 |
1
Values are group mean ± S.D. or number of subjects (n) and percent (%).
2
t-tests or X2